EVA

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA of Lassa virus prepared from cell-culture supernatant

RNA of Zaire ebolavirus isolate Ebola virus H.sapiens-tc/GIN/2014/Makona-Kissidougou-C15 extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

Serum obtained from rabbits challenged with MERS-CoV.

In vitro transcribed RNA for Lassa virus real time RT-PCR (Nikisins et al. PLoS Negl Trop Dis, 2015. https://doi.org/10.1371/journal.pntd.0003793)

RNA extracted from cell culture supernatant

Recombinant protein produced in E. coli and purified to homogeneity. Fused with a Hexa-Hisitidine tag.

Recombinant protein produced in E. coli and purified to homogeneity. Fused with a Hexa-Hisitidine tag.

Extracted RNA of an Enterovirus B isolate.

Through direct cloning and expression of the variable heavy chains (VHHs) of HCAbs from the bone marrow of MERS-CoV infected dromedaries, MERS-CoV specific VHHs or nanobodies were produced. VHH-83 binds with exceptionally high affinity to the receptor binding domain of the viral spike protein. In vitro, this VHH efficiently blocks virus entry at picomolar concentrations

Serum obtained from dromedary camels immunized with a MVA vaccine expressing the spike protein and challenged with MERS-CoV.